{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:38:34Z","timestamp":1761871114512,"version":"build-2065373602"},"reference-count":36,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.clml.2018.06.002","type":"journal-article","created":{"date-parts":[[2018,6,7]],"date-time":"2018-06-07T20:58:25Z","timestamp":1528405105000},"page":"597-602.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Bone Health and Survival in Women With Multiple Myeloma"],"prefix":"10.1016","volume":"18","author":[{"given":"Ashley E.","family":"Rosko","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erinn M.","family":"Hade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5335-7386","authenticated-orcid":false,"given":"Wenjun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4343-6723","authenticated-orcid":false,"given":"Steven","family":"Ing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca D.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Electra D.","family":"Paskett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle J.","family":"Naughton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clml.2018.06.002_bib1","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1001\/jama.2009.50","article-title":"Mortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and women","volume":"301","author":"Bliuc","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.clml.2018.06.002_bib2","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/S0140-6736(98)09075-8","article-title":"Mortality after all major types of osteoporotic fracture in men and women: an observational study","volume":"353","author":"Center","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.clml.2018.06.002_bib3","doi-asserted-by":"crossref","first-page":"E538","DOI":"10.1016\/S1470-2045(14)70442-5","article-title":"International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma","volume":"15","author":"Rajkumar","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clml.2018.06.002_bib4","first-page":"293808","article-title":"A\u00a0review on current osteoporosis research: with special focus on disuse bone loss","volume":"2011","author":"Lau","year":"2011","journal-title":"J\u00a0Osteoporos"},{"key":"10.1016\/j.clml.2018.06.002_bib5","doi-asserted-by":"crossref","first-page":"120","DOI":"10.4158\/EP12059.RA","article-title":"Secondary causes of osteoporosis","volume":"19","author":"Hudec","year":"2013","journal-title":"Endocr Pract"},{"key":"10.1016\/j.clml.2018.06.002_bib6","first-page":"897","article-title":"Osteoporosis: part I. Evaluation and assessment","volume":"63","author":"South-Paul","year":"2001","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.clml.2018.06.002_bib7","first-page":"59","article-title":"Myeloma bone disease: pathophysiology and management","volume":"2","author":"Silbermann","year":"2013","journal-title":"J\u00a0Bone Oncol"},{"issue":"Spec No A","key":"10.1016\/j.clml.2018.06.002_bib8","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1102\/1470-7330.2004.0010","article-title":"Multiple myeloma","volume":"4","author":"Collins","year":"2004","journal-title":"Cancer Imaging"},{"issue":"Spec No A","key":"10.1016\/j.clml.2018.06.002_bib9","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1102\/1470-7330.2009.9013","article-title":"Malignant versus benign vertebral collapse: are new imaging techniques useful?","volume":"9","author":"Baur-Melnyk","year":"2009","journal-title":"Cancer Imaging"},{"key":"10.1016\/j.clml.2018.06.002_bib10","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1097\/00004728-199805000-00016","article-title":"Development of vertebral fractures in patients with multiple myeloma: does MRI enable recognition of vertebrae that will collapse?","volume":"22","author":"Lecouvet","year":"1998","journal-title":"J\u00a0Comput Assist Tomogr"},{"key":"10.1016\/j.clml.2018.06.002_bib12","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s00198-011-1747-2","article-title":"Manitoba Bone Density Program. Fracture risk assessment without bone density measurement in routine clinical practice","volume":"23","author":"Leslie","year":"2012","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.clml.2018.06.002_bib13","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00198-007-0543-5","article-title":"FRAX and the assessment of fracture probability in men and women from the UK","volume":"19","author":"Kanis","year":"2008","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.clml.2018.06.002_bib14","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0197-2456(97)00078-0","article-title":"The Women\u2019s Health Initiative Study Group","volume":"19","author":"Design of the Women\u2019s Health Initiative clinical trial and observational study","year":"1998","journal-title":"Control Clin Trials"},{"issue":"9 Suppl","key":"10.1016\/j.clml.2018.06.002_bib15","doi-asserted-by":"crossref","first-page":"S122","DOI":"10.1016\/S1047-2797(03)00048-6","article-title":"WHI Morbidity and Mortality Committee. Outcomes ascertainment and adjudication methods in the Women\u2019s Health Initiative","volume":"13","author":"Curb","year":"2003","journal-title":"Ann Epidemiol"},{"key":"10.1016\/j.clml.2018.06.002_bib16","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.jocd.2008.04.003","article-title":"National Osteoporosis Foundation 2008 Clinician\u2019s Guide to Prevention and Treatment of Osteoporosis and the World Health Organization Fracture Risk Assessment Tool (FRAX): what they mean to the bone densitometrist and bone technologist","volume":"11","author":"Watts","year":"2008","journal-title":"J\u00a0Clin Densitom"},{"key":"10.1016\/j.clml.2018.06.002_bib17","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1007\/s00198-011-1713-z","article-title":"Task Force of the FRAX Initiative. Interpretation and use of FRAX in clinical practice","volume":"22","author":"Kanis","year":"2011","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.clml.2018.06.002_bib18","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s00198-011-1592-3","article-title":"High fracture probability with FRAX usually indicates densitometric osteoporosis: implications for clinical practice","volume":"23","author":"Leslie","year":"2012","journal-title":"Osteoporos Int"},{"author":"WHO scientific group on the assessment of osteoporosis at primary health care level","key":"10.1016\/j.clml.2018.06.002_bib19"},{"key":"10.1016\/j.clml.2018.06.002_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00223-011-9544-7","article-title":"FRAX((R)) with and without bone mineral density","volume":"90","author":"Kanis","year":"2012","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.clml.2018.06.002_bib21","first-page":"37","article-title":"Development and validation of a simple questionnaire to facilitate identification of women likely to have low bone density","volume":"4","author":"Lydick","year":"1998","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.clml.2018.06.002_bib22","doi-asserted-by":"crossref","first-page":"629","DOI":"10.4065\/77.7.629","article-title":"Performance of risk indices for identifying low bone density in postmenopausal women","volume":"77","author":"Geusens","year":"2002","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.clml.2018.06.002_bib23","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2307\/1402659","article-title":"Analysis of survival data under proportional hazards model","volume":"43","author":"Breslow","year":"1975","journal-title":"Int Stat Rev"},{"key":"10.1016\/j.clml.2018.06.002_bib24","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life-tables","volume":"34","author":"Cox","year":"1972","journal-title":"J\u00a0Royal Statist Soc"},{"key":"10.1016\/j.clml.2018.06.002_bib25","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1359\/JBMR.041131","article-title":"Fracture risk with multiple myeloma: a population-based study","volume":"20","author":"Melton","year":"2005","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.clml.2018.06.002_bib26","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4065\/78.1.21","article-title":"Review of 1027 patients with newly diagnosed multiple myeloma","volume":"78","author":"Kyle","year":"2003","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.clml.2018.06.002_bib27","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1056\/NEJMoa01133202","article-title":"A\u00a0long-term study of prognosis in monoclonal gammopathy of undetermined significance","volume":"346","author":"Kyle","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clml.2018.06.002_bib28","doi-asserted-by":"crossref","first-page":"5412","DOI":"10.1182\/blood-2008-12-194241","article-title":"Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study","volume":"113","author":"Landgren","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.clml.2018.06.002_bib29","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/s00774-017-0817-8","article-title":"Monoclonal gammopathy of undetermined significance and bone health outcomes: a systematic review and exploratory meta-analysis","volume":"36","author":"Veronese","year":"2018","journal-title":"J\u00a0Bone Miner Metab"},{"key":"10.1016\/j.clml.2018.06.002_bib30","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1182\/blood-2010-04-282848","article-title":"Monoclonal gammopathy of undetermined significance and risk of skeletal fractures: a population-based study","volume":"116","author":"Kristinsson","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.clml.2018.06.002_bib31","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1359\/jbmr.0301212","article-title":"Fracture risk in monoclonal gammopathy of undetermined significance","volume":"19","author":"Melton","year":"2004","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.clml.2018.06.002_bib32","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1365-2141.2006.06217.x","article-title":"Lumbar bone mineral density as the major factor determining increased prevalence of vertebral fractures in monoclonal gammopathy of undetermined significance","volume":"134","author":"Pepe","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clml.2018.06.002_bib33","doi-asserted-by":"crossref","first-page":"6529","DOI":"10.1182\/blood-2011-04-351437","article-title":"Bone microstructural changes revealed by high-resolution peripheral quantitative computed tomography imaging and elevated DKK1 and MIP-1alpha levels in patients with MGUS","volume":"118","author":"Ng","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.clml.2018.06.002_bib34","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1182\/blood-2013-05-505776","article-title":"Altered cortical microarchitecture in patients with monoclonal gammopathy of undetermined significance","volume":"123","author":"Farr","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.clml.2018.06.002_bib35","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1200\/JCO.2012.47.7901","article-title":"International Myeloma Working Group recommendations for the treatment of multiple myeloma-related bone disease","volume":"31","author":"Terpos","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clml.2018.06.002_bib36","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1016\/S0140-6736(10)62051-X","article-title":"First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trial","volume":"376","author":"Morgan","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.clml.2018.06.002_bib37","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1002\/jbmr.106","article-title":"The FRAX tool in French women: how well does it describe the real incidence of fracture in the OFELY cohort?","volume":"25","author":"Sornay-Rendu","year":"2010","journal-title":"J\u00a0Bone Miner Res"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265017319079?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265017319079?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:30:51Z","timestamp":1761870651000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265017319079"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":36,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S2152265017319079"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2018.06.002","relation":{},"ISSN":["2152-2650"],"issn-type":[{"type":"print","value":"2152-2650"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bone Health and Survival in Women With Multiple Myeloma","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2018.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}